Profil bibliographique

Leslie Cottle

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

14Publications signalées

3231Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

HIV Research and TreatmentHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV-related health complications and treatmentsHIV, Drug Use, Sexual Risk

Publications récentes

Accès ouvert 2022 articleOpenAlex

Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)

Kenneth H. Mayer, Krista Yuhas, K. Rivet Amico, Timothy Wilkin et autres

4 citationsAIDS and Behavior

Accès ouvert 2021 articleOpenAlex

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Raphael J. Landovitz, Deborah Donnell, Meredith E. Clement, Brett Hanscom et autres

905 citationsNew England Journal of Medicine

Accès ouvert 2021 erratumOpenAlex

Correction to “Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study”

Herana Kamal Seneviratne, Allyson N. Hamlin, Sue Li, Beatriz Grinsztejn et autres

0 citationsACS Pharmacology & Translational Science

Accès ouvert 2021 articleOpenAlex

Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study

Herana Kamal Seneviratne, Allyson N. Hamlin, Sue Li, Beatriz Grinsztejn et autres

2 citationsACS Pharmacology & Translational Science

Accès ouvert 2020 articleOpenAlex

Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

Raphael J. Landovitz, Sue Li, Joseph J. Eron, Beatriz Grinsztejn et autres

181 citationsThe Lancet HIV

Accès ouvert 2020 articleOpenAlex

Brief Report: Hormonal Contraception Use and Cabotegravir Pharmacokinetics in HIV-Uninfected Women Enrolled in HPTN 077

Cheríe Blair, Sue Li, Gordon Chau, Leslie Cottle et autres

16 citationsJAIDS Journal of Acquired Immune Deficiency Syndromes

Accès ouvert 2020 articleOpenAlex

Acceptability of Long-Acting Injectable Cabotegravir (CAB LA) in HIV-Uninfected Individuals: HPTN 077

Elizabeth E. Tolley, Sahar Z. Zangeneh, Gordon Chau, Joe Eron et autres

95 citationsAIDS and Behavior

Accès ouvert 2019 preprintOpenAlex

Tail-Phase Safety, Tolerability, and Pharmacokinetics of Long-Acting Injectable Cabotegravir in HIV-Uninfected Adults: HPTN 077

Raphael J. Landovitz, Sue Li, Joseph J. Eron, Beatriz Grinsztejn et autres

1 citationSSRN Electronic Journal

Accès ouvert 2018 articleOpenAlex

Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial

Raphael J. Landovitz, Sue Li, Beatriz Grinsztejn, Halima Dawood et autres

176 citationsPLoS Medicine

Accès ouvert 2018 articleOpenAlex

Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear Cells

Dominique B. Figueroa, Erin Madeen, Joseph Tillotson, Paul Richardson et autres

18 citationsAIDS Research and Human Retroviruses

Accès ouvert 2017 articleOpenAlex

Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women

Roy M. Gulick, Timothy Wilkin, Ying Qing Chen, Raphael J. Landovitz et autres

31 citationsAnnals of Internal Medicine

Accès ouvert 2016 articleOpenAlex

PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305)

Roy M. Gulick, Timothy Wilkin, Ying Qing Chen, Raphael J. Landovitz et autres

47 citationsThe Journal of Infectious Diseases

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.